The pharmaceutical contract manufacturing market growth continues to demonstrate resilience as the cell and gene therapy revolution creates entirely new categories of manufacturing demand that require specialized cleanroom infrastructure, cryogenic logistics, and living cell handling expertise. Autologous CAR-T therapies, allogeneic stem cell products, and gene replacement vectors represent...